Danaher
Beckman Coulter Life Sciences, T-NeuroDx Collaborate on Early Alzheimer's Diagnostics
The collaboration will combine T-NeuroDx's research in Alzheimer's diagnostics with Beckman Coulter's flow cytometry products.
Beckman Coulter Diagnostics Clinical Chemistry, Immunoassay Analyzer Nabs FDA Clearance
The analyzer has a throughput of up to 800 clinical chemistry tests and 100 immunoassays per hour.
In Brief This Week: T2 Biosystems, Danaher, Agilent, Lucid Diagnostics, More
News items for the week of Feb. 17, 2025.
The firm's full-year 2024 revenues were essentially flat, with core revenues declining 2 percent.
The firm said preliminary core Q4 2024 revenues are expected to be flat, exceeding prior expectations, while its China business has stabilized and will recover.